Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

Med. 2024 Feb 9;5(2):169-171. doi: 10.1016/j.medj.2024.01.013.
No abstract available

Publication types

  • Published Erratum